1Mohi MG, Neel BG. The role of Shp2 (PTPN 11) in cancer. Curr Opin Genet Dev 2007; 17:23-30.
2Chan RJ, Feng GS. PTPN 11 is the first identified proto-oncogene that encodes a tyrosine phosphatase. Blood 2007; 109:862-7.
3Ostman A, Hellberg C, Bohmer FD. Protein-tyrosine phosphatases and cancer. Nat Rev Cancer 2006; 6:307-20.
4Xu R, Yu Y, Zheng S, et al. Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia. Blood 2005; 106:3142-9.
5Chen J, Yu WM, Daino H, et al. SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl. Blood 2007;109:778-85.
6Scherr M, Chaturvedi A, Battmer K, et al. Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML). Blood 2006; 107:3279-87.
7Huang W, Saberwal G, Horvath E, et al. Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF 1 transcriptional activation by the interferon consensus sequence binding protein.Mol Cell Biol 2006;26:6311-32.
8Sattler M, Salgia R, Shrikhande G, et al. The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors. Oncogene 1997; 15:2379-84.
9Tartaglia M, Niemeyer CM, Fragale A, et al. Somatic mutations in PTPN 11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003; 34:148-50.
10Chen L, Sung SS, Yip ML, et al. Discovery of a novel shp2 protein tyrosine phosphatase inhibitor. Mol Pharmacol 2006;70:562-70.
1Huazhang An,Wei Zhao, Jin Hou, et al.SHP-2 phosphatase negatively regulates the TRIF adaptor protein-depent type linterferon and proinflammatory cytokine production.Immunity, 2006,25(6):919-928.
2Du Z, Shen Y, Yang W.Inhibition of IFN-alpha signaling by a PKC- and protein tyrosinephosphatase SHP-2-dependent pathway.Proc Natl Acad Sei USA,2005,102 (29): 102-105.
